Navigation Links
Clinical Trial Establishes Catheter-Based Aortic Valve Replacement as New Standard of Care for Patients Who Cannot Undergo Surgery
Date:9/22/2010

standard therapy). Among survivors at one year, the rate of cardiac symptoms was significantly lower among patients who had undergone TAVI, as compared with those who had received standard therapy (25.2 percent vs. 58.0 percent).

"Based on the reduction in mortality during the first year of the study, balloon-expandable TAVI should be the new standard of care in patients who are not suitable candidates for surgery," said Martin B. Leon, M.D., professor of medicine and director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital and Columbia University Medical Center. Dr. Leon, founder and chairman emeritus of the Cardiovascular Research Foundation, is the co-principal investigator of the study.

At 30 days, TAVI, as compared with standard therapy, was associated with a higher incidence of major strokes (5.0 percent vs. 1.1 percent) and major vascular complications (16.2 percent vs. 1.1 percent). In the year after TAVI, patients had no deterioration in the functioning of the bioprosthetic valve, as assessed by evidence of stenosis or regurgitation on an echocardiogram.

"This study shows that transcatheter valve replacement is a safe and effective option for this life-threatening illness in patients unsuitable for surgical valve replacement," said Dr. Smith, study co-principal investigator and surgeon-in-chief at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Smith is also the Valentine Mott Professor of Surgery, the Johnson & Johnson Distinguished Professor of Surgery, and chair of the Department of Surgery at Columbia University College of Physicians and Surgeons. "Additional studies are needed to examine the increased incidence of stroke following TAVI."

According to the study authors, research is already under way on the next generation of TAVI devices that researchers hope will address the vascular complications encountered in the trial.

Treatment of Aortic Steno
'/>"/>

SOURCE NewYork-Presbyterian Hospital/Columbia University Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  A recent study ... Knee Journal, compared the Arthrosurface HemiCAP® Wave implant, ... versus an "onlay" design implant for isolated patellofemoral ... in function and pain scores, none of the ... osteoarthritis (OA). However, 53% of the patients in ...
(Date:8/27/2015)... 27, 2015 Biosimilars are not generics ... U.S. Food and Drug Administration (FDA) for recognizing ... its draft guidance issued today. The FDA,s draft ... distinguishable names, calling for biological products to bear ... This proposal reflects the agency,s thinking that "there ...
(Date:8/27/2015)... August 27, 2015 According to a new ... Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage ... 2020", published by MarketsandMarkets, the Medical Lifting Sling Market is poised ... in 2015, at a CAGR of 11.4 % from 2015 to ... ma rket data T ables and 65 ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... , , ... 10, 2009 Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, ... clinical trial in patients chronically infected with the hepatitis C virus (HCV). ... the antiviral effect of clemizole monotherapy in the absence of interferon. ...
... LOS ANGELES, Aug. 7 A new drug delivery system that ... to the outer surface (episclera) of the eyeball may offer a ... and vitreous diseases, according to a new report by A. Linn ... at Children,s Hospital Los Angeles. Dr. Murphree is also Professor of ...
Cached Medicine Technology:Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 2Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 3Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 4
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time ... part with their subsidiary USPI Tenet Health. , The American Heart Association hosts their ... and stroke. They believe that together, a difference can be made. Walkers can participate ...
(Date:8/28/2015)... ... ... The 6th Annual Survivor in the City, Chicago silent auction and ... to its cadre of widespread support—an official letter of support and gratitude from the ... community and the University of Illinois at Chicago’s Department of Neurosurgery, the Brain Aneurysm ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
(Date:8/28/2015)... ... 28, 2015 , ... Drugs and alcohol abuse by employees ... new approach on solutions in his new book ":Unraveling The Psychological Mystery of ... together for meaningful group meetings. "This would educate the employees on not ...
(Date:8/28/2015)... ... August 28, 2015 , ... CARF International announced that ... counseling, day treatment and intensive family based services. , By pursuing and achieving ... its pursuit of excellence. As a nonprofit charity for more than 50 years, ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2
... , SHENZHEN, China, July 9 ... ), a leading developer, manufacturer and,marketer of medical devices ... for the second quarter ended June 30, 2009 after ... will hold an earnings,conference call at 8:00 AM on ...
... Legalized marriage for same-sex couples continues to be a ... California and New Hampshire ... legal recognition. Domestic partners in all states need to get smart ... covered. The National Association of Insurance Commissioners (NAIC) provides these tips ...
... TeamPraxis, Hawaii,s premier physician management service organization (MSO) ... 1,000 Hawaii physicians, capped off its inaugural year of ... market with seven new large client signings, bringing the ... , , These sales completed a very ...
... GXDX ), a provider of personalized diagnostic services, announced ... second quarter of 2009 after closing of the NASDAQ Global Market ... call hosted by President and CEO, Dr. Tina S. Nova, and ... day at 2:00pm PDT (5:00pm EDT) and will be webcast live ...
... (NYSE: CSV ) today announced plans to release 2009 ... closes. In conjunction with the release, Carriage Services has scheduled ... for Friday, July 31, 2009 at 10:30 a.m. eastern time. ... Second Quarter 2009 Earnings Conference Call, When: ...
... 9 Velos, Inc., the trusted leader in clinical ... ever-advancing mission to meet the needs of customers. "Velos ... is now being rolled out more broadly for the ... economies and benefits that support individual studies and departments ...
Cached Medicine News:Health News:Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009 2Health News:Health Insurance Options for Domestic Partnerships 2Health News:Health Insurance Options for Domestic Partnerships 3Health News:TeamPraxis Finishes Strong First Year of National Sales 2Health News:TeamPraxis Finishes Strong First Year of National Sales 3Health News:TeamPraxis Finishes Strong First Year of National Sales 4Health News:TeamPraxis Finishes Strong First Year of National Sales 5Health News:Genoptix, Inc. to Announce Second Quarter 2009 Financial Results 2Health News:Carriage Services Announces Second Quarter Earnings Release and Conference Call Schedule 2Health News:Velos, Inc. Launches 'Velos On-Demand' for Velos eResearch, Bringing Dynamically Scalable Economy to Customers 2Health News:Velos, Inc. Launches 'Velos On-Demand' for Velos eResearch, Bringing Dynamically Scalable Economy to Customers 3
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... This table is designed ... in many procedures, allowing for ... auxiliary leg is stored onboard ... Post brackets quickly slide ...
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
Light weight, clear imaging, attaches easily, perfect size, optional leg, table cart....
Medicine Products: